• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Gastroenterol Hepatol . Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, obs

tetano

Editor, Senior Moderator
Eur J Gastroenterol Hepatol


. 2022 Sep 1;34(9):925-932.
doi: 10.1097/MEG.0000000000002425. Epub 2022 Jul 27.
Gastrointestinal sequalae months after severe acute respiratory syndrome corona virus 2 infection: a prospective, observational study


Peter Liptak[SUP] 1 [/SUP], Martin Duricek[SUP] 1 [/SUP], Robert Rosolanka[SUP] 2 [/SUP], Ivana Ziacikova[SUP] 3 [/SUP], Ivan Kocan[SUP] 3 [/SUP], Peter Uhrik[SUP] 1 [/SUP], Marian Grendar[SUP] 4 [/SUP], Martina Hrnciarova[SUP] 5 [/SUP], Patricia Bucova[SUP] 6 [/SUP], David Galo[SUP] 6 [/SUP], Peter Banovcin[SUP] 1 [/SUP]



Affiliations

Abstract

Introduction: Post-coronavirus disease (post-COVID) symptoms arise mostly from impaired function of respiratory tract although in many patients, the dysfunction of gastrointestinal tract and liver among other organ systems may persist.
Methods: Primary data collection was based on a short gastrointestinal symptom questionnaire at the initial screening. A brief telephone survey within the patient and control group was performed 5-8 months after the initial screening. R ver. 4.0.5 and imbalanced RandomForest (RF) machine-learning algorithm were used for data explorations and analyses.
Results: A total of 590 patients were included in the study. The general presence of gastrointestinal symptoms 208.2 days (153-230 days) after the initial acute severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) infection was 19% in patients with moderate-to-serious course of the disease and 7.3% in patients with mild course compared with 3.0% in SARS-CoV-2 negative controls (P < 0.001). Diarrhea and abdominal pain are the most prevalent post-COVID gastrointestinal symptoms. RF machine-learning algorithm identified acute diarrhea and antibiotics administration as the strongest predictors for gastrointestinal sequelae with area under curve of 0.68. Variable importance for acute diarrhea is 0.066 and 0.058 for antibiotics administration.
Conclusion: The presence of gastrointestinal sequelae 7 months after the initial SARS-CoV-2 infection is significantly higher in patients with moderate-to-severe course of the acute COVID-19 compared with asymptomatic patients or those with mild course of the disease. The most prevalent post-COVID gastrointestinal symptoms are diarrhea and abdominal pain. The strongest predictors for persistence of these symptoms are antibiotics administration and acute diarrhea during the initial infection.
 
Back
Top Bottom